patisiran
patisiran is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including Onpattro. Available dosage form: injection, lipid complex.
Drug Details
- Generic Name
- patisiran
- Brand Names
- Onpattro
- Application Number
- NDA210922
- Sponsor
- Alnylam Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- INJECTION, LIPID COMPLEX
- Routes
- INTRAVENOUS
- Active Ingredients
- PATISIRAN SODIUM
Indications and Usage
1 INDICATIONS AND USAGE ONPATTRO is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. ONPATTRO contains a transthyretin-directed small interfering RNA and is indicated for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults.